Vistagen Therapeutics (VTGN) Net Shares Issued and Repurchased (2012 - 2023)

Vistagen Therapeutics has disclosed Net Shares Issued and Repurchased across 9 years of filings, most recently posting $10000.0 for Q2 2023.

• In Q2 2023, Net Shares Issued and Repurchased fell 98.37% year-over-year to $10000.0; the TTM figure through Jun 2023 stood at $10000.0 (down 98.37% YoY), while the FY2023 annual figure was $143900.0, down 94.1% from the prior year.
• Net Shares Issued and Repurchased came in at $10000.0 for Q2 2023 at Vistagen Therapeutics, down from $143900.0 in the prior quarter.
• In the past five years, Net Shares Issued and Repurchased ranged from a high of $1.4 million in Q4 2020 to a low of $10000.0 in Q2 2023.
• Average Net Shares Issued and Repurchased over 4 years is $565342.9, with a median of $365000.0 recorded in 2020.
• The largest YoY upside for Net Shares Issued and Repurchased was 17.06% in 2023 against a maximum downside of 98.37% in 2023.
• Over 4 years, Net Shares Issued and Repurchased stood at $1.4 million in 2020, then slipped by 7.27% to $1.3 million in 2021, then plunged by 51.76% to $615000.0 in 2022, then tumbled by 98.37% to $10000.0 in 2023.
• Per Business Quant data, the three most recent Net Shares Issued and Repurchased figures were $10000.0 in Q2 2023, $143900.0 in Q1 2023, and $615000.0 in Q2 2022.